MSD plans to share children's AIDS drugs in the patent pool of non-profit organizations
-
Last Update: 2015-02-26
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: Ding Xiangyuan 2015-02-26 according to Reuters, the US pharmaceutical company MSD has contributed a child AIDS drug in the international patent pool, which may accelerate the use of cheap paediatric drugs in poor countries The non-profit drug patent pool (MPP) aims to persuade the big bulls of pharmaceutical companies to share their product patents with generic manufacturers A statement on the 24th said that in this cooperation, the drug of MSD will be added to the list of shared drugs MSD has never participated in the program before The non-profit drug patent pool (MPP) has signed cooperation agreements with Bristol Myers Squibb, Gilead, Roche, and Viiv medical (majority owned by GlaxoSmithKline) Two months ago, the non-profit drug patent pool (MPP) signed a cooperation license with lopinavir and ritonavir, two other AIDS drugs for children MSD's licensing agreement means that other companies can sell retegway paediatric drugs in low - and middle-income countries, where 98% of children living with HIV live
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
